Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets

Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets have?

Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets has 39 citations in the OpenAlex counts ScholarIQ stores.

When was Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets published?

Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets has 2020 year in the ScholarIQ index.

What is the open-access status of Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets?

Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets has gold oa status in the ScholarIQ index.

What is the DOI of Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets?

The DOI for Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets is on the source record.

What is the PMID of Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets?

The PMID for Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets is on the source record.

What is the OpenAlex record for Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets?

The OpenAlex for Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets is on the source record.